Evaluates the influence of dietary fatty acids on alopecia areata risk, suggesting new treatment paths.
The influence of circulating polyunsaturated fatty acids (PUFAs) on alopecia areata (AA) development remains poorly understood, with inconsistent results reported. Our study aims to evaluate their causal associations using the bidirectional Mendelian randomization method. European ancestry genome-wide association studies were used to analyze the genetic associations between PUFAs and AA (n = 211,428). Sample sizes for PUFAs were 13,527, 13,506, 114,999, 7818, and 13,549 for plasma linoleic acid (LA), omega-6, omega-3, docosahexaenoic acid (DHA), and PUFAs other than 18:2 (otPUFA), respectively. The causal associations were primarily determined by the inverse variance weighted (IVW) method. Circulating omega-6 (IVW odds ratio [OR] = 1.64, 95% confidence interval [CI] = 1.15–2.33, P = .0059) and LA (IVW OR = 1.49, 95% CI = 1.05–2.13, P = .0257) were positively associated with AA risk. Conversely, AA was negatively correlated with circulating DHA (IVW OR = 0.99, 95% CI = 0.99–1.00, P = .0324). Elevated circulating omega-6 and LA are correlated with an increased AA risk. Furthermore, AA was negatively associated with circulating DHA. These findings provide insights into the potential biological mechanisms underlying the development of AA, offering potential implications for dietary recommendations and treatment options.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: